Skip to main content
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)
  • EN
  • FR
  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • COVID-19 Pandemic Resources
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
  • Links & Resources
  • Citations
NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

Main navigation

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
    • COVID-19 Pandemic Resources
    • Blood Component Transfusion Recommendations
    • Plasma Protein and Related Products Recommendations
    • Special Testing / Modification Recommendations
    • Adverse Event Recommendations
  • Links & Resources
  • Citations
  • EN
  • FR

You are here

  • Home
  • Guidelines & Recomme...
  • Blood Component Tran...
  • Massive Transfusion Consensus Conference

Guidelines & Recommendations

Massive Transfusion Consensus Conference

Summary

Update - January 23, 2012 - Critical Care - full article available:
Canadian National Advisory Committee on Blood and Blood Products; Massive Transfusion Consensus Conference, 2011: Report of the Panel

A summary of the conference proceedings is also being prepared for publication. 

Conference Presentations

Conference Questions, Panelists and Presenters

The Canadian Massive Transfusion Consensus Conference Proceedings

NAC Logo NAC Logo (English) NAC Logo (Français)
National Advisory Committee on Blood and Blood Products (NAC)

NAC

  • Blood Shortage
  • Endorsements
  • Guidelines & Recommendations
  • Links & Resources
  • Citations

Recently updated resources

  • Immunoglobulin Utilization Statement
  • Recombinant Factor VIIa
  • NAC Recommendations for Solvent Detergent Plasma (S/D Plasma)
  • National Advisory Committee (NAC) on Blood and Blood Products Position Paper: Utilization and Inventory Management of Group O RH(D)- Negative Red Cells
  • NAC Patient Blood Management Statement

Contact

NAC Chair

Andrew Shih

NAC Project Coordinator

Kendra Stuart

NationalBloodPortfolio@gov.bc.ca

© Copyright 2023. National Advisory Committee on Blood and Blood Products. All rights reserved. Disclaimer & Privacy Info